Robinson MK - Search Results

1

Coexistent genetic alterations involving ALK, RET, ROS1 or MET in 15 cases of lung adenocarcinoma.

Tang Z, Zhang J, Lu X, Wang W, Chen H, Robinson MK, Cheng J, Tang G, Medeiros LJ. Tang Z, et al. Among authors: robinson mk. Mod Pathol. 2018 Feb;31(2):307-312. doi: 10.1038/modpathol.2017.109. Epub 2017 Sep 15. Mod Pathol. 2018. PMID: 28914263 Free article.

2

Role of CDKN2C Fluorescence In Situ Hybridization in the Management of Medullary Thyroid Carcinoma.

El Naofal M, Kim A, Yon HY, Baity M, Ming Z, Bui-Griffith J, Tang Z, Robinson M, Grubbs EG, Cote GJ, Hu P. El Naofal M, et al. Ann Clin Lab Sci. 2017 Sep;47(5):523-528. Ann Clin Lab Sci. 2017. PMID: 29066476 Free PMC article.

3

Rate of reclassification of HER2-equivocal breast cancer cases to HER2-negative per the 2018 ASCO/CAP guidelines and response of HER2-equivocal cases to anti-HER2 therapy.

Crespo J, Sun H, Wu J, Ding QQ, Tang G, Robinson MK, Chen H, Sahin AA, Lim B. Crespo J, et al. Among authors: robinson mk. PLoS One. 2020 Nov 12;15(11):e0241775. doi: 10.1371/journal.pone.0241775. eCollection 2020. PLoS One. 2020. PMID: 33180796 Free PMC article. Review.

4

Acquired MET amplification in non-small cell lung cancer is highly associated with the exposure of EGFR inhibitors and may not affect patients' outcome.

Yin W, Liu W, Guo M, Tang Z, Toruner G, Robinson M, Cheng J, Hu S, Medeiros LJ, Tang G. Yin W, et al. Exp Mol Pathol. 2021 Feb;118:104572. doi: 10.1016/j.yexmp.2020.104572. Epub 2020 Nov 12. Exp Mol Pathol. 2021. PMID: 33189723

5

MET Amplification (MET/CEP7 Ratio ≥ 1.8) Is an Independent Poor Prognostic Marker in Patients With Treatment-naive Non-Small-cell Lung Cancer.

Yin W, Cheng J, Tang Z, Toruner G, Hu S, Guo M, Robinson M, Medeiros LJ, Tang G. Yin W, et al. Clin Lung Cancer. 2021 Jul;22(4):e512-e518. doi: 10.1016/j.cllc.2020.11.002. Epub 2020 Nov 17. Clin Lung Cancer. 2021. PMID: 33288441

6

Clinicopathological Features of Breast Cancer with Polysomy 17 and Its Response to Neoadjuvant Chemotherapy.

Sun H, Chen H, Crespo J, Tang G, Robinson M, Lim B, Şahin AA. Sun H, et al. Eur J Breast Health. 2021 Mar 31;17(2):128-136. doi: 10.4274/ejbh.galenos.2021.2021-2-9. eCollection 2021 Apr. Eur J Breast Health. 2021. PMID: 33870112 Free PMC article.

7

Clinicopathological features of and neoadjuvant therapy for human epidermal growth factor receptor 2-positive classic invasive lobular carcinoma.

Huang X, Chen H, Ding Q, Robinson MK, Moseley TW, Bassett RL, Tang G, Lim B, Sahin AA. Huang X, et al. Among authors: robinson mk. Hum Pathol. 2021 Nov;117:51-59. doi: 10.1016/j.humpath.2021.07.010. Epub 2021 Aug 5. Hum Pathol. 2021. PMID: 34363799

8

Clinical impact of 5^'MYC or 3^'MYC gain/loss detected by FISH in patients with aggressive B-cell lymphomas.

Tang G, Li S, Toruner GA, Jain P, Tang Z, Hu S, Xu J, Cheng J, Robinson M, Vega F, Medeiros LJ. Tang G, et al. Cancer Genet. 2023 Apr;272-273:1-8. doi: 10.1016/j.cancergen.2022.12.001. Epub 2022 Dec 18. Cancer Genet. 2023. PMID: 36566629

9

Breast Cancer With a HER2 FISH Group 2 Result: Should HER2 Tests be Repeated?

Wang M, Ding Q, Gu J, Sfamenos SM, Huo L, Tang Z, Sun H, Robinson M, Tang G, Lim B, Wu Y, Albarracin CT, Sahin AA, Chen H. Wang M, et al. Clin Breast Cancer. 2023 Jun;23(4):415-422. doi: 10.1016/j.clbc.2023.02.006. Epub 2023 Feb 12. Clin Breast Cancer. 2023. PMID: 36878823

10

Malnutrition in patients with obesity: An overview perspective.

Cristancho C, Mogensen KM, Robinson MK. Cristancho C, et al. Among authors: robinson mk. Nutr Clin Pract. 2024 Dec;39(6):1300-1316. doi: 10.1002/ncp.11228. Epub 2024 Oct 23. Nutr Clin Pract. 2024. PMID: 39439423 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

272 results

Search Page

Filters